Back to Results
First PageMeta Content
Epigenetics / Hepatology / Hepatocellular carcinoma / Sorafenib / Hep G2 / DNA methylation / Methylation / Liver cancer / Hypomethylating agent / Biology / Chemistry / Genetics


SGI-110, a novel second generation DNA hypomethylating agent, enhances sorafenib activity and alters the methylation signature of HCC cell lines No[removed]Simone Jueliger1, John Lyons1, Mohammad Azab2 and Pietro Taverna2
Add to Reading List

Open Document

File Size: 456,76 KB

Share Result on Facebook
UPDATE